Negative Pressure Wound Therapy Market Worth USD 3.2 billion by 2025 : Growing Demand From Home Care
The study involved four major activities in estimating the current size of the negative pressure wound therapy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Revenue Growth Analysis:
The negative pressure wound therapy market is expected to reach USD 3.2 billion by 2025, from USD 2.4 billion in 2020, at a CAGR of 6.1%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215139824
Key Factors Driving Market Growth:
Negative Pressure Wound Therapy (NPWT) devices are used to treat chronic wounds, such as diabetic ulcers, pressure sores, and post-operative wounds, through the application of sub-atmospheric pressure to an open wound. Growing prevalence of diabetes, increasing spending on chronic and surgical wounds, government initiatives to prevent SSIs, and high rate of cesarean sections in elderly mothers leading to increasing post-operative use of NPWT devices are some of the factors expected to drive market growth during the forecast period.
Conventional NPWT devices segment accounted for the largest share of the Negative pressure wound therapy market in 2019
Based on the product, the Negative pressure wound therapy devices market is segmented into conventional NPWT devices, disposable NPWT devices, and NPWT accessories. The conventional NPWT devices segment accounted for the largest share of this market in 2019, majorly due to better management of severe wound exudates by the portable conventional NPWT systems and their benefits—increased efficiency and reductions in the length of hospital stay, the overall cost of treatment and total disease bioburden.
Home care settings segment accounted for the largest share of the Negative pressure wound therapy market, by end-user, in 2019
Based on end-user, the Negative pressure wound therapy devices market is segmented into hospitals, home care settings, and other end users. The home care settings segment was the largest end-users of NPWT devices in 2019. The rising healthcare cost, increasing volume of surgical procedures, the increasing sale of disposables and single-use consumables, rising geriatric population, and an increase in the prevalence of age-related ailmentsare a few of the major factors driving the growth of this end-user segment.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=215139824
Regional Growth Analysis:
In 2019, North America accounted for the largest share of the Negative pressure wound therapy market. The rising geriatric population, increasing incidence of chronic wounds and diabetes, and the introduction of low-cost NPWT devices are the major factors driving the growth of the Negative pressure wound therapy devices market in North America. In addition to this, a favorable reimbursement scenario has supported market growth in this regional segment.
Key Players:
Prominent players in the Negative pressure wound therapy market include Acelity L.P. Inc. (US), Smith & Nephew (UK), Mölnlycke Healthcare AB (Sweden), ConvaTec Group Plc (UK), Cardinal Health (US), Paul Hartmann AG (Germany), DeRoyal (US), Lohmann & Rauscher International GmbH & Co KG. (Germany), Medela LLC (Switzerland), Genadyne Biotechnologies, Inc. (US), Triage Meditech Pvt. Ltd. (Delhi), Talley Group (UK), Alleva Medical Ltd. (China), Cork Medical (US), 4L Health Co. Ltd. (China), Carilex Medical GmbH (Germany), ChongQing Sunshine Medical Industry & Trading Co (China), Wuhan VSD Medical Science & Technology Co. Ltd. (China), Pensar Medical (US), and Haromed Bvba (Belgium)
Acelity L.P. Inc. (US) held the leading position in the Negative pressure wound therapy market. The company offers a comprehensive portfolio of surgical healing, patient mobility equipment, and tissue-repair therapy for acute care and serious traumas. To maintain its leading position in the Negative pressure wound therapy devices market, the company focuses on product launches and strategic acquisitions. The company has a robust portfolio of NPWT devices, including V.A.C.Ulta, VeraFlo, InfoV.A.C, ActiV.A.C., and V.A.C.Via. Acelity is a pioneer in NPWT devices and has been in the market for more than 15 years, which provides it with a competitive edge.
